BioAegis Therapeutics Stock

BioAegis Therapeutics develops a portfolio of biomarker-directed treatments across a range of indications.

Sign up today and learn more about BioAegis Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About BioAegis Therapeutics Stock

BioAegis Therapeutics, Inc. develops a portfolio of biomarker-directed treatments for a range of indications. The company was incorporated in 2011 and is based in Morristown, New Jersey.

Funding History

February 2013$3.0M
February 2014$3.7M
April 2015$8.0M
March 2016$1.5M
August 2018$4.1M


Corporate Development and Communications

Steven Cordovano

Chief Executive Officer

Susan Levinson


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: